Crossref
The low hanging fruit of anti‐inflammatory reliever therapy
Respirology · 2024
DOI: 10.1111/resp.14653 ↗At a glance
Journal article in Respirology, 2024. Written by Richard Beasley. Institution: Medical Research Institute of New Zealand, Wellington, New Zealand. Major MEDLINE topics: Budesonide, Anti-Asthmatic Agents. Cited 1 times so far (Crossref).
Abstract (original language)
Aucun résumé disponible.
Subjects
MeSH terms (MEDLINE)
BudesonideAnti-Asthmatic AgentsHumansBronchodilator AgentsAnti-Inflammatory AgentsFormoterol FumarateAdministration, InhalationEthanolaminesAdrenal Cortex HormonesDrug Combinations
Author keywords
anti-inflammatory reliever therapyasthmasevere exacerbations
Substances
BudesonideBronchodilator AgentsAnti-Inflammatory AgentsFormoterol FumarateAnti-Asthmatic AgentsEthanolaminesAdrenal Cortex HormonesDrug Combinations
Authors and institutions
- Medical Research Institute of New Zealand, Wellington, New Zealand.
ORCID profiles: Richard Beasley
Cite
APA
Beasley, R. (2024). The low hanging fruit of anti‐inflammatory reliever therapy. Respirology. https://doi.org/10.1111/resp.14653
Vancouver
Beasley R. The low hanging fruit of anti‐inflammatory reliever therapy. Respirology. 2024. doi:10.1111/resp.14653
BibTeX
@article{Beasley2024,
author = {Beasley, Richard},
title = {The low hanging fruit of anti‐inflammatory reliever therapy},
journal = {Respirology},
year = {2024},
doi = {10.1111/resp.14653}
}
EUVIMED